Source: Richard Craver, WINSTON-SALEM JOURNAL, 4/1/20


A biopharmaceutical company owned by Reynolds American Inc. has launched testing to determine whether tobacco plants can play a role in developing a coronavirus vaccine. Kentucky BioProcessing LLC has been infecting fast-growing tobacco plants with a genetically modified coronavirus to see if it could produce antibodies for a possible vaccine. Reynolds bought certain assets and liabilities of Kentucky BioProcessing in January 2014. It has made limited public comment about the subsidiary’s operations.

For more of this story, click here.